Report #2873664

Received Nov 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: NY
Recovered: Unknown
Vaccinated: Nov 17, 2025
Onset: Nov 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	DL32G	—

Symptoms (1)

Expired product administered

Symptom narrative

inadvertently an expired antigen of Arexvy was administered to a patient; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 75-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number DL32G, expiry date 03-NOV-2025) for prophylaxis. On 17-NOV-2025, the patient received Arexvy. On 17-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: inadvertently an expired antigen of Arexvy was administered to a patient). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 17-NOV-2025 Pharmacist reported that they inadvertently administered expired antigen of Arexvy to a patient, also stated that the adjuvant was not expired.